Pear Therapeutics, Inc. develops and sells software-based medicines (reSET, a treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants, reSET-O, a treatment of opioid use disorder in combination with buprenorphine, and Somryst, a software-based treatment for chronic insomnia). It is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and gastrointestinal, oncological, and cardiovascular diseases. Pear Therapeutics was incorporated in 2013 and is headquarteredin Boston, MA.
What is Pear Therapeutics's quote symbol?
What is the 52 week high and low for Pear Therapeutics (NASDAQ: PEAR)?
How much is Pear Therapeutics stock worth today?
How much is Pear Therapeutics's stock price per share?
What is Pear Therapeutics's Market Cap?